Simplex Trading, LLC Abeona Therapeutics Inc. Transaction History

Simplex Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$4.07 - $8.68 $10,638 - $22,689	-2,614 Reduced 54.82%	2,154 $15,000
Q4 2023 Feb 02, 2024	SELL	$3.71 - $5.14 $34,725 - $48,110	-9,360 Reduced 66.25%	4,768 $23,000
Q3 2023 Nov 01, 2023	BUY	$2.98 - $4.43 $39,985 - $59,441	13,418 Added 1889.86%	14,128 $59,000
Q2 2023 Aug 04, 2023	BUY	$2.76 - $5.27 $1,959 - $3,741	710 New	710 $2,000

28.4M

827K

44.5K

Ticker ABEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,950,380
Market Cap $35M
Description
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.